Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Any idea why this is dropping so drastically following the CZO merger?
-
Ceapro Inc. (CZO $0.23)
- $0.23 Cap: $17M
- View CZO Profile
- View Questions on CZO
-
COSCIENS Biopharma Inc. (AEZS)
- Cap: $7M
- View AEZS Profile
- View Questions on AEZS
Q: Hello 5i. Could you comment on the merger of CZO and AEZS . I am currently a holder of CZO and would have a profit if I sold at the current price. I am wondering if I should be happy with my CZO profit and sell or do you think that there will be upside in the merged company.
Q: Analysts have recently become quite positive about AEZS. Morningstars sees 38 per cent upside to fair value; Thomson Reuters rates is a 10/10 with a trailing P/E of 5.7 with a net margin of 34 per cent. Has your opinion changed since your last reply?
Thank you.
Thank you.
Insiders
Share Information
News and Media